![]() |
COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![]() |
University of Cambridge > Talks.cam > Foster Talks > Dendritic Potassium Channel Regulation by Fragile X Mental Retardation Protein (FMRP)
Dendritic Potassium Channel Regulation by Fragile X Mental Retardation Protein (FMRP)Add to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Philipe Mendonca. Fragile X syndrome (FXS) is a common form of mental disability and one of the known causes of autism. The mutation responsible for FXS is a large expansion of the trinucleotide CGG repeats that leads to DNA methylation of the fragile X mental retardation gene 1 (FMR1) and transcriptional silencing, resulting in the absence of fragile X mental retardation protein (FMRP), an mRNA binding protein. Although it is widely known that FMRP is critical for metabotropic glutamate receptor (mGluR)-‐ dependent long-‐term depression (LTD), which has provided a general theme for developing pharmacological drugs for FXS , specific downstream targets of FMRP may also be of therapeutic value. Since alterations in potassium channel expression level or activity could underlie neuronal network defects in FXS , we will describe our recent findings on how the dendritic potassium channel, Kv4.2 might be altered in mouse models of FXS and the possible therapeutic avenues for treating FXS . How transmitter receptors modulate neuronal signaling by regulating voltage-‐gated ion channel expression remains an open question. Recently we reported dendritic localization of mRNA of Kv4.2 voltage-‐gated potassium channel, which regulates synaptic plasticity, and its local translational regulation by FMRP . FMRP suppression of Kv4.2 is revealed by elevation of Kv4.2 in neurons from fmr1 knockout (KO) mice, and in neurons expressing Kv4.2-‐3’UTR that binds FMRP . Moreover, treating hippocampal slices from fmr1 KO mice with Kv4 channel blocker restores long-‐term potentiation (LTP) induced by moderate stimuli. The evaluation of Kv4.2 potassium channels as potential therapeutic targets for FXS will allow us to be extended to include additional proof-‐of-‐principle tests for genetic reduction of Kv4.2 as potential ways to reduce fmr1 KO mutant phenotypes, with a strong interest in pursuing translational research to develop treatments and improve outcomes for individuals with FXS . This talk is part of the Foster Talks series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsTalks related to sustainability and the environment German Society Speaker Events Synthetic Chemistry Research Interest GroupOther talksLouisiana Creole - a creole at the periphery Exhibiting Ice Age Cambridge Seminar – Why do policymakers seem to ignore your evidence? A novel aspect of Macrophage biology: learning from the great opportunist HIV-1 Hypergraph Saturation Irregularities Eukaryotic cell division and its origins |